非高密度脂蛋白胆固醇是评价血脂异常患者心血管风险的指标

doi:10.3969/j.issn.1006-7795.2014.01.016

首都医科大学学报 ›› 2014, Vol. 35 ›› Issue (1): 73-76.doi: 10.3969/j.issn.1006-7795.2014.01.016

非高密度脂蛋白胆固醇是评价血脂异常患者心血管风险的指标

张鹏睿^1,2, 徐援², 王广², 杨金奎¹

1. 首都医科大学附属北京同仁医院内分泌科, 北京 100005;
2. 首都医科大学附属北京朝阳医院内分泌科, 北京 100020

收稿日期:2013-11-27 出版日期:2014-02-21 发布日期:2014-02-21
通讯作者: 杨金奎 E-mail:jinkui.yang@163.com

Non-high density lipoprotein-cholesterol is an indicator to assess cardiovascular risk for subjects with dyslipidemia

Zhang Pengrui^1,2, Xu Yuan², Wang Guang², Yang Jinkui¹

1. Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China;
2. Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China

Received:2013-11-27 Online:2014-02-21 Published:2014-02-21

摘要/Abstract

摘要：

目的证实无论患者是否有血糖升高，非高密度脂蛋白胆固醇（non-high density lipoprotein-cholesterol，non-HDL-C）都是不弱于低密度脂蛋白胆固醇（low density lipoprotein-cholesterol，LDL-C）的评估血脂异常患者患者心血管病风险和降脂治疗疗效的有效临床指标。方法选取2007年首都医科大学附属北京同仁医院内分泌科大规模临床调查患者6 341例，检测总胆固醇（total cholesterol，TC）、高密度脂蛋白胆固醇（high density lipoprotein-cholesterol，LDL-C）、三酰甘油（triglyceride，TG），并且计算non-HDL-C（non-HDL -C等于TC-HDL-C）。根据空腹血糖高低分为血糖正常组和血糖升高组，比较两组中血脂异常患者的各项血脂指标；以non-HDL-C为纵轴，分别以LDL-C和TG为横轴作散点图。结果血糖升高组的TC、LDL-C、HDL-C、TG、non-HDL-C较血糖正常组均明显升高。作non-HDL-C与LDL-C和TG相关性的散点图并作趋势拟合线后，发现non-HDL-C与LDL-C、TG均呈线性正相关。结论 non-HDL-C是一项评估血脂异常患者心血管病风险和降脂治疗疗效的有效临床指标。

关键词: 非高密度脂蛋白胆固醇, 低密度脂蛋白胆固醇, 血脂异常, 血糖升高

Abstract:

Objective To confirm that non-high density lipoprotein-cholesterol (non-HDL-C) is an effective clinical indicator to assess the cardiovascular disease (CVD) risk and lipid-lowering therapy regardless of glucose level. Methods A total of 6 341 subjects were selected from large-scale clinical survey of the Department of Endocrinology, Beijing Tongren Hospital in 2007. Fasting blood samples were collected from each subject and were tested for total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), HDL-C, triglyceride (TG) and non-HDL-C was calculated by subtracting TC from HDL-C. The subjects were divided into euglycemia group and hyperglycemia group according to fasting glucose level and the other parameters of the 2 groups were compared. Results TC, LDL-C, HDL-C, TG and non-HDL-C in hyperglycemia group were higher than that in euglycemia group. A linear positive correlation was found between non-HDL-C and LDL-C, non-HDL-C and TG. Conclusion non-HDL-C is an effective clinical indicator to assess the cardiovascular decease risk and lipid-lowering therapy.

Key words: non-high density lipoprotein-cholesterol, low density lipoprotein-cholesterol, dyslipidemia, hyperglycemia

中图分类号:

R543

张鹏睿, 徐援, 王广, 杨金奎. 非高密度脂蛋白胆固醇是评价血脂异常患者心血管风险的指标[J]. 首都医科大学学报, 2014, 35(1): 73-76.

Zhang Pengrui, Xu Yuan, Wang Guang, Yang Jinkui. Non-high density lipoprotein-cholesterol is an indicator to assess cardiovascular risk for subjects with dyslipidemia[J]. Journal of Capital Medical University, 2014, 35(1): 73-76.

参考文献

[1] Expert Panel on Dection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program(NCEP)Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ)[J].JAMA, 2001, 285(19):2486-2497.

[2] 李健斋.非高密度脂蛋白胆固醇——新提出的降脂治疗第二目标[J].临床检验杂志, 2004, 22(1):1-2.

[3] 方圻, 王钟林, 宁田海, 等. 血脂异常防治建议[J]. 中华心血管病杂志, 1997, 25(3):169-172.

[4] 赵志诚.阿托伐他汀治疗老年冠心病合并血脂异常32例[J].中国煤炭工业医学杂志, 2012, 15(6):879.

[5] 王芊, 华川, 郭旭, 等.同型半胱氨酸等危险因子与冠心病的相关性分析[J].临床误诊误治, 2012, 25(3):42-44.

[6] 张润军, 杨丽霞.冠心病危险因素与冠状动脉病变的相关性分析[J].解放军医药杂志, 2011, 23(1):7-11.

[7] Grundy S M. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome[J]. Am J Cardiol, 1998, 81(4A):18B-25B.

[8] Havel R J. Role of triglyceride-rich lipoproteins in progression of atherosclerosis[J]. Circulation, 1990, 81(2):694-696.

[9] Iso H, Naito Y, Sato S, et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women[J]. Am J Epidemiol, 2001, 153(5):490-499.

[10] Yamamoto A, Richie G, Nakamura H, et al. Risk factors for coronary heart disease in the Japanese comparison of the background of patients with acute coronary syndrome in the ASPAC study with data obtained from the general population. Asia-Pacific Collaboration on CHD Risk Factor Intervention study[J]. J Atheroscler Thromb, 2002, 9(4):191-199.

[11] Grundy S M. Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target[J]. Arch Intern Med, 2001, 161(11):1379-1380.

[12] Packard C J, Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk[J]. J Atheroscler Thromb, 2004, 11(1):6-14.

[13] Liu J, Sempos C T, Donahue R P, et al. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease[J]. Am J Cardiol, 2006, 98(10):1363-1368.

[14] Vega G L, Grundy S M. Does measurement of apolipoprotein B have a place in cholesterol management?[J]. Arteriosclerosis, 1990, 10(5):668-671.

非高密度脂蛋白胆固醇是评价血脂异常患者心血管风险的指标

Non-high density lipoprotein-cholesterol is an indicator to assess cardiovascular risk for subjects with dyslipidemia

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

本文评价

[1]	徐建可, 刘宁, 韩苗, 张洪阳, 韩新生. 缺血性脑卒中患者颈动脉斑块性质与非高密度脂蛋白胆固醇浓度的相关性[J]. 首都医科大学学报, 2023, 44(1): 49-53.
[2]	任春琦, 孔羽, 伏圣高, 朱正炎, 杜昕. 中青年钙化性主动脉瓣疾病的特征及危险因素分析[J]. 首都医科大学学报, 2022, 43(2): 187-191.
[3]	阮祥燕, 崔亚美, Diethelm Wallwiener, Alfred O. Mueck. 绝经激素治疗与代谢综合征风险研究进展[J]. 首都医科大学学报, 2014, 35(4): 387-391.
[4]	余焕玲;毕研霞;肖荣;麻微微;向丽;丁冰杰;何玲玲. β谷固醇对高脂饲料喂养小鼠空问学习记忆能力的影响[J]. 首都医科大学学报, 2008, 29(6): 724-727.
[5]	曹雪霞;王立. 2型糖尿病患者血糖对血脂的影响及相关性分析[J]. 首都医科大学学报, 2006, 27(1): 90-91.
[6]	李红兵;武宝玉;刘微;谢荣荣. 调脂治疗对血浆胰岛素水平的影响[J]. 首都医科大学学报, 2005, 26(1): 87-89.
[7]	冯伟捷;刘玄重;刘金;张剑峰;彭名炜;王孝蓉;张月英;王淑敏;吴烯云. 美降脂对30例高脂血症病人的疗效观察[J]. 首都医科大学学报, 1992, 13(4): 273-276.